Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma.

J Neurooncol · 2021 · PMC8437873 · PMID 34322829

Europe PMC DOI

hedged sentence

0.0806

closest p · 1.6× alpha

0.0806

boldest claim

The sentences

showed a trendp = 0.0806so close (0.05 < p ≤ 0.1)

CDKN2A status and EGFR status showed a trend toward poor prognosis ( CDKN2A , HR 2.73, 95% CI 0.88–8.42, p = 0.0806; EGFR , HR 6.56, 95% CI 0.75–2.45, p = 0.0649) (Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.